Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com
Patient Information Leaflet last updated on the eMC: 12/08/2009
PIL Actilyse

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 20/08/2008 and displayed until 12/08/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 21/01/2008 and displayed until 20/08/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 21/12/2007 and displayed until 21/01/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/11/2007 and displayed until 21/12/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/06/2007 and displayed until 28/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 10/01/2003 and displayed until 08/06/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 06/12/2000 and displayed until 10/01/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   alteplase


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk